笔名: Myron 于November 01, 19115 00:44:04:

I'd like to pay this cheque in, please cheap research paper Abraxane plus gemcitabine demonstrated a 59 percent increase in one-year survival, 35 percent vs 22 percent. The combination also doubled the percentage of patients who survived for two years from the start of treatment, with 9 percent still alive compared with 4 percent for gemcitabine alone.

答复此贴